Skip to main content

Table 4 Reported outcomes – Western Ontario and McMaster Universities osteoarthritis instrument (WOMAC) following intraarticular injection of autologous conditioned serum/autologous protein solution (ACS/APS)

From: Autologous cell-free serum preparations in the management of knee osteoarthritis: what is the current clinical evidence?

Author and year

Study patients

Age at presentation

Mean (± SD)/median (range)

Follow-up (months)

Mean (± SD)/median (range)

Outcome measure

Baseline

Post procedure

Score

Mean (± SD)/median (range)

Time point(s) (weeks/months)

Score

Mean (± SD)/median (range)

Kon et al. 2018 [22]

46

57 (41–68)

12 (± NR)

WOMAC

51.2 (± NR)

12 months

NRa

Hang et al. 2017

92

NR

12 (± NR)

WOMAC

Function – 70.3 (± NR)

12 months

Function – 27.2 (± NR)

Mobility – 8.6 (± NR)

12 months

Mobility – 3.1 (± NR)

Pain – 20.9 (± NR)

12 months

Pain – 9.0 (± NR)

Shirokova et al. 2017 [34]

123

59.9 (± 8.8)

3 (± NR)

WOMAC

NRb

3 months

NRb

Hix et al. 2017 [20]

10

58.8 (± 9.5)

12 (± NR)

WOMAC

Pain – 12.0 (± 1.2)

12 months

Pain – 3.3 (± 2.9)

van Drumpt et al. 2016 [21]

10

57.5 (± 9.5)

18 (± 1)

WOMAC

55 (± NR)

12 months

20 (± NR)

Garcia-Escudero et al. 2015 [35]

118

59 (34–81)

24 (± NR)

WOMAC

Global – 81.6 (± NR)

12 months

Global – 35.2 (± NR)

Function – 60.4 (± NR)

12 months

Function – 29.4 (± NR)

Stiffness – 3.36 (± NR)

12 months

Stiffness – 3.3 (± NR)

Pain – 17.9 (± NR)

12 months

Pain – 2.5 (± NR)

Motaal et al. 2014 [37]

30

54.21 (± 5.95)

3 (± NR)

WOMAC

Total – 45.63 (± 9.99)

1 week

Total – 26.23 (± 11.50)

1 month

Total – 8.0 (± 7.28)

2 months

Total – 7.52 (± 6.91)

3 months

Total – 8.27 (± 5.45)

Baltzer et al. 2009 [38]

376

53.8 (± 12.2)

25 (± NR)

WOMAC

Global – 5.24 (± 2.32)

7 weeks

Global – 2.80 (± 2.30)

13 weeks

Global – 2.42 (± 2.06)

26 weeks

Global – 2.42 (± 2.19)

Pain – 5.18 (± 2.39)

7 weeks

Pain – 2.71 (± 2.37)

13 weeks

Pain – 2.33 (± 2.14)

26 weeks

Pain – 2.42 (± 2.25)

Stiffness – 5.59 (± 2.7)

7 weeks

Stiffness – 3.07 (± 2.49)

13 weeks

Stiffness – 2.80 (± 2.33)

26 weeks

Stiffness – 2.78 (± 2.45)

Function – 5.21 (± 2.41)

7 weeks

Function – 2.80 (± 2.34)

13 weeks

Function – 2.40 (± 2.08)

26 weeks

Function – 2.37 (± 2.21)

Yang et al. 2008 [39]

153

54 (± 11)

12 (± NR)

WOMAC

54.49 (± 17.6)

3 months

63.37 (± 20.6)

6 months

62.90 (± 23.7)

9 months

61.78 (± 23.4)

12 months

65.02 (± 24.1)

  1. NR
  2. aWOMAC at 12 months reported to be 49% better but numeric score not provided
  3. bWOMAC at 3 months reported to be 28.7% better but numeric score not provided